홈 › 비소세포폐암 › 일리노이 › Springfield
IL Springfield의 비소세포폐암 임상 시험
비소세포폐암 관련 연구 14개가 Springfield 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
피험자 모집 중3상
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
피험자 모집 중3상
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
피험자 모집 중3상
- Springfield Clinic Main Campus, Springfield
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
피험자 모집 중관찰 연구
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
피험자 모집 중3상
- Springfield Clinic Main Campus, Springfield
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
피험자 모집 중2상
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
피험자 모집 중3상
- Springfield Clinic Main Campus, Springfield
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
피험자 모집 중2상
- Springfield Clinic - First /ID# 272576, Springfield
Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2상
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2상
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2상
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2/3상
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
피험자 모집 중1상
- Southern Illinois University - Simmons Cancer Institute, Springfield
- Springfield Clinic Radiology - 800 Building, Springfield
- Springfield Clinic Urgent Care Plus, Springfield
- 외 4개
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
피험자 모집 중2상
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
다른 도시의 비소세포폐암 시험
- Houston, TX연구 143개
- New York City, NY연구 123개
- Arlington, VA연구 111개
- Nashville, TN연구 97개
- Los Angeles, CA연구 92개
- Boston, MA연구 87개
- St. Louis, MO연구 68개
- Baltimore, MD연구 60개
- San Antonio, TX연구 60개
- Chicago, IL연구 59개
- Columbus, OH연구 57개
- Seattle, WA연구 55개
Springfield의 다른 연구
- 폐암연구 13개
- 대장직장암연구 9개
- 유방암연구 8개
- 급성 골수성 백혈병연구 8개
- 신장암 (신세포암)연구 6개
- 방광암연구 6개
- 전립선암연구 6개
- 두경부 편평세포암연구 6개
- 암 (전체)연구 5개
- 췌장암연구 5개
- 흑색종연구 5개
- 전이성 암연구 4개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.